Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors

The summary for the Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors: The purpose of the Centers for Disease Control and Prevention National Center for Injury Prevention and Control (NCIPC) Mentored Research Scientist Development Award (K01) is to provide support for an intensive, supervised/mentored career development experience in substance use and/or overdose prevention research leading to research independence. NCIPC supports K01 grants to help ensure the availability of an adequate number of trained scientists to address critical public health research questions to prevent polydrug use and overdose. Applicants must propose a research project that aims to better understand and identify risk and protective factors related to polydrug initiation, use, and escalation. This could include, but is not limited to, co-use of opioids, stimulants, and/or cannabis. Additionally, research can focus the examination of potential moderators of risk and protective factors for polydrug initiation, use and escalation; and/or can investigate the relationship between polydrug use and overdose. Research should be conducted among persons experiencing a disproportionate burden of substance use disorders and overdose, which may include but are not limited, to those people in certain socio-demographic groups (e.g. non-English speaking populations, tribal populations, rural communities, racial/ethnic minority groups, sexual and gender minority groups), people experiencing certain social determinants of health (e.g., reduced economic stability; limited educational attainment, access or quality; limited healthcare access or quality including those who have been historically underserved or are uninsured; limited access to substance use treatment; limited health literacy; those in geographically underserved areas), people experiencing certain social or physical health conditions (e.g., homelessness, a mental health condition, chronic pain, incarceration or recent release from incarceration, a disability, a history of substance use disorders and/or overdose), and people who have experienced adverse childhood experiences; and people with a history of suicidal ideation or suicide attempt.